2022年英語論文

1．Aomura D, Kurasawa Y, Harada M, Hashimoto K, Kamijo Y: Brain MRI detection of early Wernicke’s encephalopathy in a hemodialysis patient. Clin Case Rep 10 (3) e05539, 2022
2．Aomura D, Kurasawa Y, Harada M, Hashimoto K, Kamijo Y: Early detection of thiamine deficiency by non-thyroidal illness syndrome in a hemodialysis patient. CEN Case Rep 2022
3．Ashihara N, Ota M, Fujinaga Y, Ozawa M, Kuraishi Y, Watanabe T, Hamano H, Joshita S, Kawa S, Umemura T: The levels of IL-1beta and soluble IL-1 receptors in patients with IgG4-related periaortitis/periarteritis. Adv Med Sci 67 (2) 257-261, 2022
4．Fujimori N, Kimura T, Tanaka N, Yamazaki T, Okumura T, Kobayashi H, Wakabayashi SI, Yamashita Y, Sugiura A, Pham J, Pydi SP, Sano K, Joshita S, Umemura T: 2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease. Hepatol Res 52 (4) 352-363, 2022
5．Fujiyoshi Y, Inoue H, Shimamura Y, Fujiyoshi MRA, de Santiago ER, Nishikawa Y, Toshimori A, Tanabe M, Sumi K, Ono M, Iwaya Y, Ikeda H, Onimaru M: Association between endoscopic pressure study integrated system (EPSIS) and high-resolution manometry. Endosc Int Open 10 (6) E762-E768, 2022
6．Fujiyoshi Y, Inoue H, Shimamura Y, Fujiyoshi MRA, Rodriguez de Santiago E, Nishikawa Y, Toshimori A, Tanabe M, Sumi K, Iwaya Y, Ono M, Izawa S, Ikeda H, Onimaru M: Comparison of scope holding sign on endoscopy and lower esophageal sphincter contraction on high-resolution manometry: A pilot study. DEN Open 2 (1) e50, 2022
7．Hara D, Okamura T, Iwaya Y, Nagaya T, Ota H, Umemura T: Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development. Helicobacter 27 (6) e12934, 2022
8．Harada M, Nakajima T, Yamada Y, Aomura D, Yamaguchi A, Sonoda K, Tanaka N, Hashimoto K, Kamijo Y: Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study. J Clin Med 11 (3) 2022
9．Harada M, Yamaguchi A, Sonoda K, Yamada Y, Aomura D, Kamimura Y, Hashimoto K, Ichikawa T, Kobayashi M, Kamijo Y: Comparison of the factors associated with the short-term prognosis between elderly and non-elderly patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a retrospective observational study. Clin Exp Rheumatol 40 (4) 705-713, 2022
10．Horiuchi I, Horiuchi A, Umemura T: Serum Leucine-Rich alpha2 Glycoprotein: A Biomarker for Predicting the Presence of Ulcerative Colitis but Not Ulcerative Proctitis. J Clin Med 11 (21) 2022
11．Ikeuchi H, Sugiyama H, Sato H, Yokoyama H, Maruyama S, Mukoyama M, Hayashi H, Tsukamoto T, Fukuda M, Yamagata K, Ishikawa E, Uchida K, Kamijo Y, Nakagawa N, Tsuruya K, Nojima Y, Hiromura K: A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan. Clin Exp Nephrol 26 (9) 898-908, 2022
12．Inayama E, Yamada Y, Kishida M, Kitamura M, Nishino T, Ota K, Takahashi K, Shintani A, Ikenoue T: Effect of Music in Reducing Pain during Hemodialysis Access Cannulation: A Crossover Randomized Controlled Trial. Clin J Am Soc Nephrol 17 (9) 1337-1345, 2022
13．Iwadare T, Kimura T, Kunimoto H, Tanaka N, Wakabayashi SI, Yamazaki T, Okumura T, Kobayashi H, Yamashita Y, Sugiura A, Joshita S, Umemura T: Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD. Biomedicines 10 (11) 2022
14．Iwadare T, Kimura T, Tanaka N, Yamazaki T, Wakabayashi SI, Okumura T, Kobayashi H, Yamashita Y, Pydi SP, Nakajima T, Iwaya M, Sugiura A, Joshita S, Uehara T, Umemura T: Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients. Sci Rep 12 (1) 18900, 2022
15．Iwaya M, Kobayashi S, Nakayama Y, Kato S, Kurasawa S, Sado T, Iwaya Y, Uehara T, Ota H: Number and distribution of eosinophils and lymphocytes in the Japanese pediatric gastrointestinal tract: in search of a definition for “abnormally increased eosinophils”. World J Pediatr 2022
16．Joshita S: Toward the accumulation of evidence for a novel high-sensitivity hepatitis B core-related antigen assay in patients with hepatitis B virus infection. Hepatol Res 52 (9) 743-744, 2022
17．Kamakura M, Uehara T, Iwaya M, Asaka S, Kobayashi S, Nakajima T, Kinugawa Y, Nagaya T, Yoshizawa T, Shimizu A, Ota H, Umemura T: LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer. Diagn Pathol 17 (1) 21, 2022
18．Kamakura M, Uehara T, Iwaya M, Asaka S, Kobayashi S, Nakajima T, Kinugawa Y, Nagaya T, Yoshizawa T, Shimizu A, Ota H, Umemura T: LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer. Diagn Pathol 17 (1) 21, 2022
19．Kimura T, Pydi SP, Wang L, Haspula D, Cui Y, Lu H, Konig GM, Kostenis E, Steinberg GR, Gavrilova O, Wess J: Adipocyte G(q) signaling is a regulator of glucose and lipid homeostasis in mice. Nat Commun 13 (1) 1652, 2022
20．Kobayashi R, Calo NC, Marcon N, Iwaya Y, Shimamura Y, Honda H, Streutker C, Mosko J, May G, Teshima C: Predictors of recurrence of dysplasia or cancer in patients with dysplastic Barrett’s esophagus following complete eradication of dysplasia: a single-center retrospective cohort study. Surg Endosc 36 (7) 5041-5048, 2022
21．Korenaga M, Murata K, Izumi N, Tamaki N, Yokosuka O, Takehara T, Sakamoto N, Suda G, Nishiguchi S, Enomoto H, Ikeda F, Yanase M, Toyoda H, Genda T, Umemura T, Yatsuhashi H, Yamasaki K, Ide T, Toda N, Kanda T, Nirei K, Ueno Y, Haga H, Nishigaki Y, Nakane K, Omata M, Mochizuki H, Aoki Y, Imamura M, Kanto T, Mizokami M: No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy. Glob Health Med 4 (4) 216-224, 2022
22．Murahashi M, Kogami A, Muramoto A, Hoshino H, Akama TO, Mitoma J, Goi T, Hirayama A, Okamura T, Nagaya T, Kobayashi M: Vascular E-selectin Expression Detected in Formalin-fixed, Paraffin-embedded Sections With an E-selectin Monoclonal Antibody Correlates With Ulcerative Colitis Activity. J Histochem Cytochem 70 (4) 299-310, 2022
23．Nakajima T, Uehara T, Iwaya M, Matsuda K, Wada M, Nagaya T, Ehara T, Ota H: Osteopontin expression in the invasive front stroma of colorectal adenocarcinoma is associated with tumor budding and prognosis. Pathology – Research and Practice 240 154190, 2022
24．Nakazawa H, Sakai K, Sudo Y, Iwabuchi R, Sakai H, Nishina S, Kawakami T, Kawakami F, Matsuzawa S, Ito T, Kitahara M, Kamijo Y, Umemura T, Ushiki A, Kanai S, Tsuchiya H, Ishida F: Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients. Transpl Immunol 75 101713, 2022
25．Ohira H, Takahashi A, Zeniya M, Abe M, Arinaga-Hino T, Joshita S, Takaki A, Nakamoto N, Kang JH, Suzuki Y, Sogo T, Inui A, Koike K, Harada K, Nakamoto Y, Kondo Y, Genda T, Tsuneyama K, Matsui T, Tanaka A: Clinical practice guidelines for autoimmune hepatitis. Hepatol Res 52 (7) 571-585, 2022
26．Ohmiya N, Hirata I, Sakamoto H, Morishita T, Saito E, Matsuoka K, Nagaya T, Nagata S, Mukae M, Sano K, Suzuki T, Tarumi KI, Shimizu S, Kawashima K, Hibi T: Multicenter epidemiological survey of pneumatosis intestinalis in Japan. BMC Gastroenterol 22 (1) 272, 2022
27．Okamura T, Iwaya Y, Nagaya T, Muranaka F, Ota H, Umemura T: Gastric adenocarcinoma arising from hamartomatous inverted polyp during 8-year follow-up. DEN Open 2 (1) e16, 2022
28．Okamura T, Iwaya Y, Iwaya M, Koizumi T, Nagaya T: Gastric Cancer After Helicobacter pylori Eradication for Nodular Gastritis in an Adolescent. Cureus 14 (10) e29984, 2022
29．Okumura T, Joshita S, Sugiura A, Ota M, Umemura T: Quantitative changes of lipoprotein(a) in chronic hepatitis C patients achieving a sustained virological response by direct-acting antivirals. Clin Res Hepatol Gastroenterol 46 (8) 102011, 2022
30．Okumura T, Noguchi T, Sekiguchi N, Kobayashi T, Kanda S, Ida K, Minagawa T, Tokumaru S, Umemura T, Koizumi T: Clinical analysis of extrapulmonary neuroendocrine carcinoma: a retrospective and single institution experience. Chemotherapy 2022
31．Roshanzadeh A, Yadav AK, Pydi SP, Kimura T, Jang BC: Expression and Role of beta3-Adrenergic Receptor during the Differentiation of 3T3-L1 Preadipocytes into Adipocytes. Biology (Basel) 11 (5) 2022
32．Sakamoto K, Ito K, Yotsuyanagi H, Yatsuhashi H, Tanaka Y, Hige S, Takikawa Y, Ueno Y, Yamamoto K, Imazeki F, Inoue J, Kurosaki M, Umemura T, Toyoda H, Mita E, Michitaka K, Maeshiro T, Yamada N, Suetsugu A, Kawanaka M, Seko Y, Matsuura K, Okumura A, Fukuzawa Y, Sugiyama M, Mizokami M, Yoneda M: Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan. J Gastroenterol 57 (12) 971-980, 2022
33．Senzaki D, Yoshioka N, Nagakawa O, Inayama E, Nakagawa T, Takayama H, Endo T, Nakajima F, Fukui M, Kijima Y, Oyama Y, Kudo R, Toyama T, Yamada Y, Tsurusaki K, Aoyama N, Matsumura T, Yamahara H, Miyasato K, Kitamura T, Ikenoue T: Modeling Low Muscle Mass Screening in Hemodialysis Patients. Nephron 1-9, 2022
34．Sonoda K, Harada M, Aomura D, Hara Y, Yamada Y, Yamaguchi A, Hashimoto K, Kamijo Y: Relationship between glomerular number in fresh kidney biopsy samples and light microscopy samples. Clin Exp Nephrol 2022
35．Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T, Nakamoto N, Takaki A, Kang JH, Joshita S, Suzuki Y, Koike K, Inui A, Tanaka A, Japan Autoimmune Hepatitis Study G: Risk factors for relapse of autoimmune hepatitis in Japan: A nationwide survey. Hepatol Res 52 (7) 597-602, 2022
36．Takahashi Y, Nagaya T, Iwaya Y, Okamura T, Hirayama A, Iwaya M, Uehara T, Umemura T: CD8(+) Lymphocyte Infiltration Is a Specific Feature of Colitis Induced by Immune Checkpoint Inhibitors. Dig Dis Sci 2022
37．Trier AM, Mack MR, Fredman A, Tamari M, Ver Heul AM, Zhao Y, Guo CJ, Avraham O, Ford ZK, Oetjen LK, Feng J, Dehner C, Coble D, Badic A, Joshita S, Kubo M, Gereau RWt, Alexander-Brett J, Cavalli V, Davidson S, Hu H, Liu Q, Kim BS: IL-33 signaling in sensory neurons promotes dry skin itch. J Allergy Clin Immunol 149 (4) 1473-1480 e1476, 2022
38．Umemura T, Fujinaga Y, Ashihara N, Ozawa M, Kuraishi Y, Watanabe T, Hamano H, Meguro A, Kawa S, Ota M: IL1R1 gene variants associate with disease susceptibility to IgG4-related periaortitis/periarteritis in IgG4-related disease. Gene 820 146212, 2022
39．Wang WL, Kasamatsu J, Joshita S, Gilfillan S, Di Luccia B, Panda SK, Kim DH, Desai P, Bando JK, Huang SC, Yomogida K, Hoshino H, Fukushima M, Jacobsen EA, Van Dyken SJ, Ruedl C, Cella M, Colonna M: The aryl hydrocarbon receptor instructs the immunomodulatory profile of a subset of Clec4a4(+) eosinophils unique to the small intestine. Proc Natl Acad Sci U S A 119 (23) e2204557119, 2022
40．Watanabe R, Oshima M, Nishioka N, Sada KE, Nagasaka K, Akiyama M, Ando T, Higuchi T, Inoue Y, Kida T, Mutoh T, Nakabayashi A, Onishi A, Sakai R, Waki D, Yamada Y, Yajima N, Tamura N, Kaname S, Harigai M: Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis. Mod Rheumatol 2022
41．Yamada A, Harada M, Nobuoka T, Yamaguchi A, Sonoda K, Hashimoto K, Kamijo Y: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Developing Pancreatic Lesion and Diabetes Mellitus: A Case Report and Review of the Literature. Tohoku J Exp Med 256 (2) 161-168, 2022
42．Yoshizawa T, Uehara T, Iwaya M, Asaka S, Kobayashi S, Nakajima T, Kinugawa Y, Nagaya T, Kamakura M, Shimizu A, Kubota K, Notake T, Masuo H, Hosoda K, Sakai H, Hayashi H, Umemura K, Kamachi A, Goto T, Tomida H, Yamazaki S, Ota H, Soejima Y: Correlation of LGR5 expression and clinicopathological features in intrahepatic cholangiocarcinoma. Pathol Res Pract 232 153832, 2022
43．Zhang X, Diao P, Yokoyama H, Inoue Y, Tanabe K, Wang X, Hayashi C, Yokoyama T, Zhang Z, Hu X, Nakajima T, Kimura T, Nakayama J, Nakamuta M, Tanaka N: Acidic Activated Charcoal Prevents Obesity and Insulin Resistance in High-Fat Diet-Fed Mice. Front Nutr 9 852767, 2022
44．Zhang Z, Diao P, Zhang X, Nakajima T, Kimura T, Tanaka N: Clinically Relevant Dose of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor alpha Modulator (SPPARMalpha), Lowers Serum Triglyceride Levels by Targeting Hepatic PPARalpha in Mice. Biomedicines 10 (7) 2022